Clinical Trials Browser

Meningioma × Hydroxyurea × Sarcoma × Clear all

NCT00354913 2013-01-18

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Phase 2 Completed

21 enrolled 8 charts

Brain Neoplasms, Glioblastoma, Meningioma, Gliosarcoma